|
|
||||||||
Ann Thorac Surg 2004;77:410-414
© 2004 The Society of Thoracic Surgeons
a University of Texas Southwestern Medical Center at Dallas, CRSTI, Medical City Hospital, Dallas, Texas, USA
* Address reprint requests to Dr Doolabh, 4511C Bowser Ave, Dallas, TX 75219, USA.
e-mail: nsdoolabh{at}aol.com
Presented at the Thirty-ninth Annual Meeting of The Society of Thoracic Surgeons, San Diego, CA, Jan 31Feb 2, 2003.
| Abstract |
|---|
|
|
|---|
METHODS: Between January 1997 and December 2002, 180 patients with palmar, axillary, facial, or plantar hyperhidrosis underwent a thoracoscopic sympathectomy. Surgical technique evolved during our study period and included excision of the sympathetic ganglia at T2, T3, or T4 depending on the location of the sweating using monopolar cautery.
RESULTS: Patient demographics included 33% males (59/180) and 67% females (121/180), with a mean age of 29.2 years old (range 12 to 76 years old). Ethnic origin was 67% white (122/180), 19% Asian (34/180), 8% Black (14/180), and 6% Hispanic (10/180). Positive family history of hyperhidrosis was noted in 57%. Preoperatively, 49% patients (86/180) had palmar sweating only, 7% patients (12/180) axillary only, 24% patients (43/180) palmar and axillary, 16% patients (28/180) face/scalp only, and 7% patients (11/180) all of the above; additionally 69% patients (125/180) had plantar hyperhidrosis. All procedures were performed through 3-mm and 5-mm ports, and 98% (177/180) were completed as an outpatient procedure. Complications included a mild temporary Horner's Syndrome (n = 1; 0.5%), air leak requiring chest drainage (n = 9; 5%), and bleeding (n = 3; 1.6%) requiring thoracoscopic reexploration (n = 1) and chest drainage (n = 2). Success rates were palmar 100% (109/109), axillary 98% (48/49), and face/scalp 93% (26/28). Plantar hyperhidrosis responded with improvement in 82% (72/88) of all patients. Seventy-eight percent patients (96/123) experienced compensatory hyperhidrosis, usually affecting the stomach, chest, back, and neck. Overall satisfaction was 94% (139/148).
CONCLUSIONS: Thoracoscopic sympathectomy is a safe and effective outpatient method for managing hyperhidrosis. Although overall satisfaction is high, patients should be fully informed about the potential for compensatory sweating.
| Introduction |
|---|
|
|
|---|
Early surgical management for hyperhidrosis required an open thoracotomy. This was accompanied by a prolonged recovery period and significant morbidity including Horner's syndrome [3, 4]. However, with recent advances in video-assisted thoracoscopy, upper thoracic dorsal sympathectomy has emerged as a viable first line treatment for essential hyperhidrosis.
The incidence and severity of complications following treatment with video-assisted thoracoscopy has been shown to decline, with reported incidences of Horner's syndrome ranging from 0 to 1.9% [511]. This study is a retrospective review of 180 consecutive patients undergoing thoracoscopic sympathectomy at our institution to analyze the indications for, success of, and safety with this modality of treatment for essential hyperhidrosis.
| Material and methods |
|---|
|
|
|---|
|
|
|
| Results |
|---|
|
|
|---|
|
|
| Comment |
|---|
|
|
|---|
Thoracic sympathectomy for hyperhidrosis was first described in the 1920s by Kotzareff [13]. The original approach was a two-stage procedure, which involved a dorsal paravertebral incision for access to the sympathetic chain. Since that original report, multiple open surgical approaches have been developed, most of which are associated with significant morbidity. The approaches included the anterior supraclavicular [14], posterior paravertebral [15], posterior midline [16], anterior thoracic [17], axillary thoracic [18], and the axillary extrathoracic with first rib resection [19]. Acceptance of surgical sympathectomy for hyperhidrosis proved limited as the risks of surgery were thought to outweigh the potential benefits in this benign condition. Kux advocated an endoscopic technique as early as 1954 [6]. Recent advancements in videooptics and specialized instrumentation have significantly facilitated sympathectomy. The sympathetic trunk can be easily identified through the parietal pleura thoracoscopically and surgical division of the trunk can be safely performed with minimal associated morbidity.
Our operative technique has evolved with experience. A few points are worth noting. First, downsizing trocars to 3 mm has significantly diminished postoperative pain (even compared with 5-mm ports). Typical postoperative analgesic requirements are two to four propoxyphene tablets in the first 24 to 48 hours only. Second, although the procedure can be performed through open ports without CO2 insufflation, the addition of CO2 pressure markedly enhances visualization by displacing the lung and expediting the procedure. Similarly, use of a double lumen endotracheal tube, although not necessary, is a major facilitating aspect. Third, elimination of postoperative chest drainage has proven to be safe and less painful and expedites recovery. Any intrathoracic air leak is immediately apparent at closure and can be easily managed by a catheter placed to a Heimlich valve. Removal is usually possible within 1 to 24 hours. This method of air leak management has been sufficient in all patients.
The excellent view of the ganglion, together with adequate magnification, allows for precise division of the ganglion, which results in lower incidences of Horner's syndrome (0.4% to 2.4%) when compared with open sympathectomy [8, 10, 11, 20]. In our series only 1 patient (0.55%) developed a temporary Horner's syndrome. Other complications, including air leak requiring chest drainage and bleeding, were relatively uncommon in accordance with other series [8, 10, 11, 2023].
Seventy-six percent of our patients experienced compensatory hyperhidrosis, usually affecting the upper abdomen, lower back, inner thighs, and behind the knees. Other series have reported compensatory hyperhidrosis occurring in between 67% and 85% of their patients (Table 3) [2427]. The incidence and degree of compensatory sweating appear to depend on the extent of resection of the sympathetic chain, which may account for the differences in various series. Our technique involves limited excision of the ganglia at T2, T3, or T4 depending upon the patient's symptom complex. Only the level necessary for response (T2 for face/scalp, T3 for hands, T4 for axilla) is excised to minimize compensatory symptoms. Methods described for performing sympathectomy include simple transection of the sympathetic ganglion, ablation with cautery or laser, or simple clipping of the sympathetic chain with titanium clips. Clipping of the sympathetic chain, without division or ablation, allows the theoretical advantage of reversal should the symptoms of compensatory sweating become unbearable. In our experience, the desire for reversibility is rare (2 patients) neither of which was apparent early when the procedure was potentially reversible by clip removal. Because of this, as well as theoretical potential for reinnervation with clipping, has kept us from adopting the clip technique. Irrespective of the chosen method of sympathetic chain disruption, the success rates as well as the incidence of postoperative compensatory sweating are quite similar (Table 4). In the majority of patients in our study the compensatory sweating was only a minor inconvenience compared with their preoperative symptoms and our overall satisfaction rate for the procedure at 1-year follow-up was 94%. When compensatory hyperhidrosis is moderate or severe, management is difficult and generally unsatisfactory. We use systemic or topical anticholinergics with variable success. We have referred 1 patient for sural nerve reversal with no benefit.
|
|
| Discussion |
|---|
|
|
|---|
Thank you very much.
DR DOOLABH: Thank you for your questions and comments. Regarding the level of resection, our technique has evolved during our operative period to the point where we now perform a T3 resection for palmar hyperhidrosis. In our experience, we believe by limiting our excision to the T3 ganglia, our dissection is further away from the stellate ganglion, which may reduce our amount of postoperative compensatory hyperhidrosis and Horner's syndrome. Despite resecting only T3 for this disease process, our results show a 100% complete resolution of palmar symptoms.
To answer your second question regarding the number of incisions, we believe by using three 3-mm ports, this allows us to perform our operation in an expedient fashion, it allows us to utilize the aid of an assistant, and we believe this shortens our operative time, leading to less postoperative discomfort. Our average operative time is 29.3 minutes for a bilateral sympathectomy from skin incision to completion of the procedure. The majority of our patients are operated on Friday, as an outpatient, and most report returning to work the following Monday.
DR ERIC VALLIERES (Seattle, WA): Excellent results, beautiful presentation. You did not mention anything about the nerve of Kuntz. In the literature, there is a lot of emphasis on the need to divide this nerve to minimize the risks of failures. Would you comment, please.
DR DOOLABH: We don't make any attempts to resect the nerve of Kuntz. The nerve of Kuntz is reported in the literature to be present in about 10% of the population and represents an aberrant connection between the T3 ganglia and the brachial plexus, in effect, bypassing the circuit of the sympathetic chain. We believe the increased amount of dissection needed to ablate the nerve of Kuntz can contribute to worsening postoperative pain and increase the surgical morbidity of this procedure. We believe our results of recurrence and compensatory symptoms are comparable to that of other published series.
(Slide) This is a slide with various other published series, and you can see, despite not resecting the nerve of Kuntz, our response rates are fairly similar. And on the next slide our compensatory rates, despite the various methods of controlling this disease process, are as well similar to other published series.
DR JOSE RIBAS M. CAMPOS (São Paulo, Brazil): How do you manage your compensatory hyperhidrosis when this occurs? Do you have any problem with the use of CO2 during the anesthetic procedure? We know about some records in the literature showing that problems can occur.
And finally, on the right side, sometimes you can find big intercostal veins, and how do you manage that? When this happens, you just choose sympathictomy or do you perform the sympathectomy?
DR DOOLABH: Regarding severe compensatory hyperhidrosis, we believe the best treatment for severe compensatory hyperhidrosis is, naturally, avoidance. With that said, we minimize our amount of dissection and extent of resection in order to decrease the incidence of this postoperative complication. We have had 2 patients report to us debilitating symptoms and request reversal of this procedure, 1 patient has undergone reversal, and the second patient is waiting for the results of the first.
With regard to the use of CO2 insufflation, we believe this again improves our visualization and the case of the operation. Having said that, we do monitor our patients with an arterial line. Should they develop hemodynamic compromise from tension pneumothorax-related symptoms, we should be able to pick that up in a fairly expeditious fashion.
Regarding aberrant venous anatomy on the right side precluding this operation, there have been reports of failure of this operation given the presence of an azygos lobe or abnormal venous connections. We quite honestly, fortunately I think, have not run into this problem but would certainly need to modify our approach if this problem arose. Again, this is a benign disease process, so invoking a surgical operation that may cause significant morbidity is not necessarily in the patients best interest.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
H. A. Tetteh, S. S. Groth, T. Kast, B. A. Whitson, D. M. Radosevich, A. C. Klopp, J. D'Cunha, M. A. Maddaus, and R. S. Andrade Primary Palmoplantar Hyperhidrosis and Thoracoscopic Sympathectomy: A New Objective Assessment Method Ann. Thorac. Surg., January 1, 2009; 87(1): 267 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Walles, G. Somuncuoglu, V. Steger, S. Veit, and G. Friedel Long-term efficiency of endoscopic thoracic sympathicotomy: survey 10 years after surgery Interactive CardioVascular and Thoracic Surgery, January 1, 2009; 8(1): 54 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, Y.-R. Tu, M. Lin, F.-C. Lai, J.-F. Chen, and Z.-J. Dai Endoscopic thoracic sympathectomy for palmar hyperhidrosis: a randomized control trial comparing t3 and t2-4 ablation. Ann. Thorac. Surg., May 1, 2008; 85(5): 1747 - 1751. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Jeganathan, S. Jordan, M. Jones, S. Grant, O. Diamond, K. McManus, A. Graham, and J. McGuigan Bilateral thoracoscopic sympathectomy: results and long-term follow-up Interactive CardioVascular and Thoracic Surgery, February 1, 2008; 7(1): 67 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rocco Endoscopic VATS sympathectomy: the uniportal technique MMCTS, May 7, 2007; 2007(0507): 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Tassi, R. J. O. Davies, and M. Noppen Advanced techniques in medical thoracoscopy. Eur. Respir. J., November 1, 2006; 28(5): 1051 - 1059. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Murphy, J. Ghosh, N. Khwaja, D. Murray, A. T. Halka, A. Carter, N. J. Turner, and M. G. Walker Upper dorsal endoscopic thoracic sympathectomy: a comparison of one- and two-port ablation techniques. Eur. J. Cardiothorac. Surg., August 1, 2006; 30(2): 223 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Dewey, M. A. Herbert, S. L. Hill, S. L. Prince, and M. J. Mack One-Year Follow-Up After Thoracoscopic Sympathectomy for Hyperhidrosis: Outcomes and Consequences Ann. Thorac. Surg., April 1, 2006; 81(4): 1227 - 1233. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Molins, J. J. Fibla, J. Perez, A. Sierra, G. Vidal, and C. Simon Outpatient thoracic surgical programme in 300 patients: clinical results and economic impact Eur. J. Cardiothorac. Surg., March 1, 2006; 29(3): 271 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kumagai, H. Kawase, and M. Kawanishi Health-Related Quality of Life After Thoracoscopic Sympathectomy for Palmar Hyperhidrosis Ann. Thorac. Surg., August 1, 2005; 80(2): 461 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Elia, G. Guggino, D. Mineo, G. Vanni, A. Gatti, and T. C. Mineo Awake one stage bilateral thoracoscopic sympathectomy for palmar hyperhidrosis: a safe outpatient procedure Eur. J. Cardiothorac. Surg., August 1, 2005; 28(2): 312 - 317. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Ponce Gonzalez, G. Julia Serda, N. Santana Rodriguez, P. Rodriguez Suarez, G. Perez Penate, J. Freixinet Gilart, and P. Cabrera Navarro Long-term pulmonary function after thoracic sympathectomy J. Thorac. Cardiovasc. Surg., June 1, 2005; 129(6): 1379 - 1382. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Haider and N. Solish Focal hyperhidrosis: diagnosis and management Can. Med. Assoc. J., January 4, 2005; 172(1): 69 - 75. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |